Implementation and Evaluation of an Alternative Electronic Health Record Tool for Ordering Blood Products in Pediatric Oncology and Stem Cell Transplantation: Mixed Methods Analysis - Summary - MDSpire

Implementation and Evaluation of an Alternative Electronic Health Record Tool for Ordering Blood Products in Pediatric Oncology and Stem Cell Transplantation: Mixed Methods Analysis

  • By

  • Ally Sarna

  • Aya Finkelstein

  • Caroline Malcolmson

  • Renee Potashner

  • Natalie Pitch

  • Alessia Forestieri

  • Marilyn Cooper

  • Yuquing Feng

  • Aryan Patel

  • Tal Schechter

  • Karim Jessa

  • Lillian Sung

  • Adam P Yan

  • May 15, 2026

  • 0 min

Share

Objective:

To understand the usage patterns of transfusion therapy plans and their impact on efficiency, safety, and clinician experience in pediatric oncology, particularly focusing on workflow and error reduction.

Key Findings:
  • Transfusion therapy plans allow for longitudinal reuse of orders, potentially reducing order entry errors.
  • The therapy plans are designed to improve adherence to transfusion volume guidelines.
  • Hard stops prevent ordering of excessive transfusion volumes, enhancing patient safety.
Interpretation:

The implementation of transfusion therapy plans is expected to streamline the ordering process, enhance safety, and improve clinician workflow in pediatric oncology settings.

Limitations:
  • The study is limited to a single institution, which may affect generalizability. Additionally, the lack of informed consent may limit insights into participant engagement and perceptions.
Conclusion:

Transfusion therapy plans represent a promising advancement in electronic health record systems for pediatric oncology, aiming to improve the safety and efficiency of blood product ordering, ultimately enhancing patient care.

Original Source(s)

Implementation and Evaluation of an Alternative Electronic Health Record Tool for Ordering Blood Products in Pediatric Oncology and Stem Cell Transplantation: Mixed Methods Analysis

  • by Ally Sarna, Aya Finkelstein, Caroline Malcolmson, Renee Potashner, Natalie Pitch, Alessia Forestieri, Marilyn Cooper, Yuquing Feng, Aryan Patel, Tal Schechter, Karim Jessa, Lillian Sung, Adam P Yan

  • May 15, 2026

Related Content

Diffuse large B-cell lymphoma presenting as a scalp tumor with skull destruction and neurological symptoms: a case report

Synthetic short RNA in cancer

MRI perfusion in evaluating ovarian masses: diagnostic performance of wash out rate